MedTrace Logo

Pathogen Specific Immunity in Patients With Sarcoidosis

NCT00217789 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 5

Last updated 2013-12-24

No results posted yet for this study

Summary

The purpose of this study is to assess the lung cells of healthy volunteers and patients with stage II and III pulmonary sarcoidosis for pathogen specific memory immunity and gene expression patterns.

Conditions

  • Sarcoidosis

Interventions

PROCEDURE

Bronchoalveolar Lavage and Venipuncture

Sponsors & Collaborators

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • University of Medicine and Dentistry of New Jersey

    lead OTHER

Principal Investigators

  • Stephan Schwander, MD, PhD · University of Medicine and Dentistry of New Jersey

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-07-31
Primary Completion
2008-06-30
Completion
2008-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00217789 on ClinicalTrials.gov